IL-1 signaling mediates intrauterine inflammation and chorio-decidua neutrophil recruitment and activation

Lipopolysaccharides 0301 basic medicine Neutrophils Immunology Apoptosis Reproductive health and childbirth Low Birth Weight and Health of the Newborn Minor Histocompatibility Antigens 03 medical and health sciences Preterm Pregnancy Receptors Infant Mortality Decidua Animals Humans Amnion Pediatric Inflammation Reproductive Biology 0303 health sciences Interleukin-8 Infant, Newborn Infant Chorion Perinatal Period - Conditions Originating in Perinatal Period Newborn Macaca mulatta 3. Good health Infectious Diseases Good Health and Well Being Chorioamnionitis Interleukin-1 Receptor-Associated Kinases Proto-Oncogene Proteins c-bcl-2 Neutrophil Infiltration Cytokines Female Signal Transduction Interleukin-1
DOI: 10.1172/jci.insight.98306 Publication Date: 2018-03-21T15:01:17Z
ABSTRACT
Neutrophil infiltration of the chorioamnion-decidua tissue at the maternal-fetal interface (chorioamnionitis) is a leading cause of prematurity, fetal inflammation, and perinatal mortality. We induced chorioamnionitis in preterm rhesus macaques by intraamniotic injection of LPS. Here, we show that, during chorioamnionitis, the amnion upregulated phospho-IRAK1-expressed neutrophil chemoattractants CXCL8 and CSF3 in an IL-1-dependent manner. IL-1R blockade decreased chorio-decidua neutrophil accumulation, neutrophil activation, and IL-6 and prostaglandin E2 concentrations in the amniotic fluid. Neutrophils accumulating in the chorio-decidua had increased survival mediated by BCL2A1, and IL-1R blockade also decreased BCL2A1+ chorio-decidua neutrophils. Readouts for inflammation in a cohort of women with preterm delivery and chorioamnionitis were similar to findings in the rhesus macaques. IL-1 is a potential therapeutic target for chorioamnionitis and associated morbidities.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (91)
CITATIONS (80)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....